Regencell Bioscience Holdings Limited(RGC:US)
Market Cap$4.742B
Key Metrics
Price$9.59
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand-
Total Assets$3.01M
Net Assets$1.22M
Total Debt$0
Key Metrics
Price$9.59
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand-
Total Assets$3.01M
Net Assets$1.22M
Total Debt$0
Financials
| Name |
|---|
Revenue |
Cost of Revenue |
Gross Profit |
| Research and Development |
| Selling, General, and Administrative |
| Other Operating Expenses |
Operating Income |
| Non-Operating Interest Income |
| Non-Operating Interest Expense |
| Other Income/Expense |
Income Before Tax |
Income Tax |
Net Income |
Minority Interests |
Preferred Stock Dividends |
Net Income to Common |
Shares Outstanding (Basic) |
Shares Outstanding (Diluted) |
EPS (Basic) |
EPS (Diluted) |
EBIT |
EBITDA |